Brachytherapy with iridium-192 for bladder cancer

Citation
H. Van Poppel et al., Brachytherapy with iridium-192 for bladder cancer, EUR UROL, 37(5), 2000, pp. 605-608
Citations number
21
Categorie Soggetti
Urology & Nephrology
Journal title
EUROPEAN UROLOGY
ISSN journal
03022838 → ACNP
Volume
37
Issue
5
Year of publication
2000
Pages
605 - 608
Database
ISI
SICI code
0302-2838(200005)37:5<605:BWIFBC>2.0.ZU;2-C
Abstract
Objective: Patients with invasive bladder cancer often need radical cystect omy with its implications on quality of life, Bladder preservation combinin g surgery and radiotherapy could maintain quality of life without compromis ing tumor control. Study Design: Twenty-eight selected patients with different stages of invas ive bladder cancer were treated with preoperative external beam radiotherap y in a dosage depending on the tumor stage. Subsequently they underwent sur gical exploration with or without partial cystectomy and insertion of sourc e carrier tubes for afterloading with iridium-192. A close follow-up consis ted of 3-monthly urine cytology, cystoscopy and yearly CT scan. Results: Sixteen patients (57%) are alive with no evidence of disease. Five patients (18%) have died of non-cancer-related causes without evidence of recurrent tumor, Tumor progression was seen in 7 patients (25%). Conclusions: Interstitial radiation can result in long-term complete remiss ion in patients with small solitary invasive bladder tumors. The afterloadi ng technique is safe and effective. The selection of patients is the most r elevant key to success. Copyright (C) 2000 S. Karger AG, Basel.